Israel’s Migal Galilee Research Institute is now MigVax Corp and has just received $12 million of funds, led by Ourcrowd. MigVax is developing a safe, oral vaccine with 3 levels of protection. It will be easy to scale up and can be adjusted for other coronavirus strains.

https://www.businesswire.com/news/home/20200421005579/en/OurCrowd-Leads-12-Million-Investment-Israeli-COVID-19

https://medium.com/@CEOOURCROWD/six-reasons-why-ourcrowd-is-investing-in-this-israeli-covid-19-vaccine-570f109f1eff